How is polycystic ovary syndrome diagnosed in a woman of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosing Polycystic Ovary Syndrome (PCOS)

PCOS is diagnosed in women of reproductive age when at least two of the following three criteria are present: oligo- or anovulation, clinical or biochemical hyperandrogenism, and polycystic ovarian morphology on ultrasound—after excluding other disorders that mimic PCOS. 1

Diagnostic Criteria (Rotterdam Criteria)

The diagnosis requires any two of three features 1, 2:

  1. Ovulatory dysfunction: Menstrual cycle length >35 days or fewer than 8 cycles per year 1, 3
  2. Hyperandrogenism (clinical or biochemical):
    • Clinical: hirsutism, acne, or androgenic alopecia 1, 3
    • Biochemical: elevated androgens on laboratory testing 4, 1
  3. Polycystic ovarian morphology: ≥20 follicles (2–9 mm) per ovary or ovarian volume >10 mL on ultrasound 1, 3

Clinical History and Physical Examination

Essential History Elements 1, 3

  • Menstrual pattern: Document cycle length, regularity, and duration of irregularity 1
  • Androgen excess timeline: Gradual onset suggests PCOS; rapid onset (<6 months) with severe virilization suggests androgen-secreting tumor 1, 3
  • Medication review: Exogenous androgens, hormonal contraceptives 1
  • Family history: Cardiovascular disease, diabetes, PCOS 1, 3
  • Lifestyle factors: Diet, exercise patterns, weight changes 1

Physical Examination Findings 1, 3

  • Hyperandrogenism signs: Hirsutism (modified Ferriman-Gallwey score), acne distribution, male-pattern balding, clitoromegaly 1
  • Insulin resistance markers: Calculate BMI and waist-hip ratio (>0.9 indicates central obesity); look for acanthosis nigricans 1, 5
  • Exclude Cushing's syndrome: Buffalo hump, moon facies, abdominal striae, proximal muscle weakness 1, 5

Laboratory Testing

First-Line Androgen Assessment 4, 1, 5

Total testosterone (TT) and free testosterone (FT) measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS) are the recommended first-line tests. 4, 1

  • Total testosterone: 74% sensitivity, 86% specificity 4, 5
  • Calculated free testosterone: 89% sensitivity, 83% specificity (highest sensitivity) 4, 1
  • LC-MS/MS method: Superior specificity (92%) versus direct immunoassay (78%) 4, 5
  • Free Androgen Index (FAI): 78% sensitivity, 85% specificity; calculate from TT and SHBG when LC-MS/MS unavailable 4, 1

Second-Line Androgen Tests (if TT/FT normal but clinical suspicion high) 4, 1, 5

  • Androstenedione (A4): 75% sensitivity, 71% specificity; useful when SHBG is low 4, 1
  • DHEAS: 75% sensitivity, 67% specificity; values >3800 ng/mL (age 20–29) suggest non-classic congenital adrenal hyperplasia 1, 5

Mandatory Exclusion Tests 1, 5, 3

  • TSH: Rule out thyroid disease as cause of menstrual irregularity 1, 5
  • Prolactin: Morning resting level; >20 µg/L is abnormal (PCOS patients have 3.15-fold increased risk of hyperprolactinemia) 1, 5
  • 17-hydroxyprogesterone: If DHEAS elevated, to exclude non-classic congenital adrenal hyperplasia 1, 5

Metabolic Screening (mandatory for all PCOS patients) 1, 5

  • 2-hour oral glucose tolerance test (75 g glucose load): Fasting glucose >7.8 mmol/L indicates diabetes 1, 5
  • Fasting lipid panel: Total cholesterol, LDL, HDL, triglycerides 1, 5
  • Fasting glucose and insulin: Glucose/insulin ratio >4 suggests insulin resistance 1, 5

Ultrasound Assessment

Optimal Imaging Technique 4, 1, 3

Transvaginal ultrasound with ≥8 MHz transducer frequency is the gold standard in adults. 4, 1

Diagnostic Thresholds 4, 1, 3

  • Follicle number per ovary (FNPO) ≥20 follicles (2–9 mm diameter): 87.6% sensitivity, 93.7% specificity—this is the primary criterion 4, 1
  • Ovarian volume >10 mL: 81.5% sensitivity, 81.0% specificity—use when accurate follicle counting is impossible 4, 1
  • Follicle number per single cross-section (FNPS): Secondary alternative marker 1

Critical Age-Specific Considerations 4, 1, 6

Do not use ultrasound for PCOS diagnosis in adolescents <20 years old or <8 years post-menarche due to high false-positive rates (normal multifollicular ovaries are common). 4, 1, 6 In adolescents, rely on clinical/biochemical hyperandrogenism plus menstrual irregularity persisting 2–3 years beyond menarche. 1, 6

Important Ultrasound Pitfalls 1, 3

  • Polycystic ovarian morphology appears in 17–22% of asymptomatic women without PCOS 1, 2
  • Ovarian volume <3 cm³ with <5 antral follicles suggests diminished ovarian reserve, not PCOS, and requires evaluation for premature ovarian insufficiency 1

Anti-Müllerian Hormone (AMH)

Do not use AMH as a standalone diagnostic test for PCOS. 1, 5 Although AMH ≥35 pmol/L shows 92% sensitivity and 97% specificity in research settings, lack of assay standardization, absence of validated cut-offs, and significant overlap between women with and without PCOS preclude clinical use. 1, 5, 6 AMH should not replace ultrasound for detecting polycystic ovarian morphology. 1

Differential Diagnosis: Mandatory Exclusions 1, 5, 3

Before confirming PCOS, exclude:

  • Cushing's syndrome: Buffalo hump, moon facies, hypertension, abdominal striae, proximal myopathy 1, 5
  • Androgen-secreting tumors: Rapid onset (<6 months), severe virilization, testosterone >150–200 ng/dL, androstenedione >10 nmol/L 1, 5
  • Non-classic congenital adrenal hyperplasia: Elevated DHEAS, measure 17-hydroxyprogesterone 1, 5
  • Thyroid disease: Measure TSH 1, 5
  • Hyperprolactinemia: Measure prolactin; confirm elevation with 2–3 samples at 20–60 minute intervals if elevated 1, 5
  • Primary ovarian failure: FSH >35–50 IU/L indicates premature ovarian insufficiency 1
  • Hypothalamic amenorrhea: Low LH, no hyperandrogenism, history of excessive exercise or low body weight 1, 5

Diagnostic Algorithm

  1. Clinical assessment: Document menstrual irregularity (cycle >35 days) and signs of hyperandrogenism (hirsutism, acne, alopecia) 1, 3

  2. Laboratory testing:

    • Measure TT and FT by LC-MS/MS 4, 1
    • Measure TSH and prolactin to exclude mimics 1, 5
    • If TT/FT normal but clinical suspicion high, measure A4 and DHEAS 4, 1

  3. Ultrasound (if needed to meet diagnostic criteria):

    • Transvaginal ultrasound with ≥8 MHz transducer 4, 1
    • Count follicles per ovary (≥20 is diagnostic) 4, 1
    • If follicle counting impossible, measure ovarian volume (>10 mL is diagnostic) 4, 1
    • Skip ultrasound in adolescents <20 years or <8 years post-menarche 4, 1, 6

  4. Metabolic screening (all patients):

    • 2-hour oral glucose tolerance test 1, 5
    • Fasting lipid panel 1, 5

  5. Diagnosis confirmed: If ≥2 of 3 Rotterdam criteria present after exclusions 1, 2

Special Diagnostic Scenarios

Adolescents (<20 years, ≥1 year post-menarche) 1, 6

  • Require both irregular menstrual cycles (defined by time post-menarche) and clinical/biochemical hyperandrogenism for diagnosis 6
  • Do not use ultrasound or AMH 1, 6
  • Adolescents with only one feature are "at risk" and require symptom management and follow-up 6

Patients on Hormonal Contraception 1

  • Progestin-only implants (e.g., Implanon) suppress the hypothalamic-pituitary-ovarian axis, making hormone levels unreliable 1
  • Remove implant or allow expiration before testing TT, FT, LH, FSH 1
  • Combined oral contraceptives similarly alter androgen levels and SHBG 1

When Ultrasound Is Not Needed 1

If the patient has both irregular menstrual cycles and clinical/biochemical hyperandrogenism, ultrasound is not necessary for diagnosis (two Rotterdam criteria already met), though it will identify the complete phenotype. 1

Common Diagnostic Pitfalls

  • False-positive androgens: Direct immunoassays have 78% specificity versus 92% for LC-MS/MS; always use LC-MS/MS when available 4, 5
  • Normal testosterone does not exclude PCOS: 30% of women with confirmed PCOS have normal testosterone levels 1, 5
  • LH/FSH ratio >2 is unreliable: Abnormal in only 35–44% of PCOS cases 1, 5
  • Polycystic ovaries alone are insufficient: Up to one-third of reproductive-age women without PCOS have polycystic ovarian morphology 1, 2
  • Transient multifollicular appearance: Can occur after discontinuing birth control; does not represent true PCOS 1
  • Excessive exercise: Can cause hypothalamic amenorrhea mimicking PCOS but without hyperandrogenism 1

References

1
Guideline

Diagnostic Criteria and Treatment Options for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

2
Research

Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome.

Best practice & research. Clinical obstetrics & gynaecology, 2004

3
Guideline

Initial Workup for Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

5
Guideline

Laboratory Evaluations for Suspected Polycystic Ovary Syndrome (PCOS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the appropriate workup for Polycystic Ovary Syndrome (PCOS)?
What laboratory tests are recommended for the workup of polycystic ovary syndrome (PCOS)?
In a reproductive‑age woman presenting with irregular menstrual cycles, hirsutism, acne, or infertility, how should polycystic ovary syndrome be evaluated and what are the recommended management strategies if diagnosed?
What is the diagnostic approach for a female patient of reproductive age with suspected Polycystic Ovary Syndrome (PCOS)?
In a reproductive‑age woman being evaluated for polycystic ovary syndrome, are total testosterone, sex hormone‑binding globulin, free testosterone, human chorionic gonadotropin, and prolactin the appropriate labs to order?
What is the appropriate immediate management and work‑up for a hypertensive patient presenting with hyponatremia (serum sodium 128 mmol/L), mild hypochloremia, borderline hypercalcemia, mildly elevated AST/ALT, macrocytosis, and thrombocytosis?
What is the appropriate management for a hemoglobin A1c of 5.8% (pre‑diabetes)?
What does a platelet count of 420 × 10⁹/L (≈420 000/µL) indicate?
For a male patient with a purulent scrotal wound, should I obtain wound cultures and baseline laboratory studies, including blood cultures?
How should a patient with mediastinal adenopathy, bilateral diffuse patchy multilobar ground‑glass mosaic opacities, tachycardia, tachypnea, and a history of asthma be managed?
What is the relationship between darkening of the skin on the neck or axillae (acanthosis nigricans) and insulin resistance?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question